Improving gout care with a personalized action plan in Singapore
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study helps people with gout create a personal action plan with their doctor to better manage flare-ups and prevent future attacks. It aims to improve gout care in Singapore's primary care clinics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or older
- You have been diagnosed with gout by a doctor
- You have had at least one gout flare-up in the past year
- You can read and speak English
- You are a Singapore citizen or permanent resident
- You are not pregnant and do not have any serious mental or cognitive conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
This trial tests a digital tool to help people with serious illnesses and their caregivers plan future medical care. It may help you discuss your goals and treatments with your doctor and family.
This study looks at ways to improve how gout is managed after a visit to the emergency room. It aims to help you get better follow-up care and prevent future flares.
This study tests whether using a smartphone or tablet to monitor your gout from home can help manage the condition. You may qualify if you have had at least one gout flare in the last year and have high uric acid levels.
This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.
Hear when a new Gout Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.